Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center

Aiwen Wu,Lin Wang,Changzheng Du,Yifan Peng,Yunfeng Yao,Jun Zhao,Tiancheng Zhan,Yong Cai,Yongheng Li,Yingshi Sun,Jiafu Ji
DOI: https://doi.org/10.3760/cma.j.issn.1671-0274.2017.04.011
2017-01-01
Abstract:Objective To investigate the safety and efficacy of organ preservation surgery or "watch and wait" strategy for rectal cancer patients who are evaluated as clinical complete response (cCR) or near-cCR following neoadjuvant chemoradiotherapy (nCRT).Method From March 2011 to June 2016,35 patients with mid-low rectal cancers who were diagnosed as cCR or near-cCR following nCRT underwent organ preservation surgery with local excision or surveillance following "watch and wait" strategy in the Peking University Cancer Hospital.All the patients received re-evaluation and re-staging 6-12 weeks after the completion of nCRT,according to Habr-Gama and MSKCC criteria for the diagnosis of cCR or near-cCR.The near-cCR patients who received local excision and were pathologically diagnosed as T0Nx were also regarded as cCR.The end-points of this study included organ-preservation rate (OPR),sphincter-preservation rate (SPR),non-re-growth disease-free survival (NR-DFS),stoma-free survival,cancer-specific survival (CSS) and overall survival (OS).Kaplan-Meier curve was used to estimate the survival data at 3 years.Results A total of 35 cases were analyzed including 24 males (68.6%) and 11 females (31.4%).The median age was 60 (range 37-79) years and the median distance from tumor to anal edge was 4 (2-8) cm.Thirty-three patients received 50.6 Gy/22f IMRT with capecitabine and two patients received 50 Gy/25f RT with capecitabine.The cCR and near-cCR rates were 74.3%(26/35) and 25.7% (9/35) respectively.Excision biopsy was performed in 4 near-cCR cases to confirm the diagnosis of cCR.The non-re-growth DFS rate was 14.3%(5/35) and the median time of tumor re-growth was 6.7 (4.7-37.4) months.In five patients with tumor re-growth,four were salvaged by radical rectal resections and one received local excision.The distant metastasis rate was 5.7% (2/35),one patient presented resectable liver metastasis and received radical resection,another patient presented multiple bone metastases and was still alive.The median follow-up time was 43.7 (6.1-71.4) months.At three years,the organ-preservation rate was 88.6% (31/35),the sphincter-preservation rate was 97.1% (34/35).No local recurrence was observed in five patients who received salvage surgery.The non-re-growth DFS was 94.0%.Three patients died of non-rectal cancer related events.The cancer-specific survival was 100%,the overall survival was 92.7% and the stoma-free survival rate was 90.0%.Conclusions Organ preservation surgery or "watch and wait" strategy for cCR or near-cCR patients is feasible and achieves good outcomes.This strategy can be an alternative to standard care,improve patient's quality of life and facilitate tailored treatment for mid-low rectal cancer following nCRT,however,it should be cautiously applied in near-cCR patients before local excision biopsy.
What problem does this paper attempt to address?